Chemical Compound Review:
Mesantoin 5-ethyl-3-methyl-5-phenyl- imidazolidine-2...
Synonyms:
Insulton, Methoin, Mefenetoin, Phenantoin, MEPHENYTOIN, ...
- Clinical pharmacology of mephenytoin and ethotoin. Troupin, A.S., Friel, P., Lovely, M.P., Wilensky, A.J. Ann. Neurol. (1979)
- Disposition of mephenytoin and its metabolite, nirvanol, in epileptic patients. Theodore, W.H., Newmark, M.E., Desai, B.T., Kupferberg, H.J., Penry, J.K., Porter, R.J., Yonekawa, W.D. Neurology (1984)
- Liver disease selectively modulates cytochrome P450--mediated metabolism. Frye, R.F., Zgheib, N.K., Matzke, G.R., Chaves-Gnecco, D., Rabinovitz, M., Shaikh, O.S., Branch, R.A. Clin. Pharmacol. Ther. (2006)
- Mephenytoin phenotyping: lack of haematologic effect and timing of urine collections. Relling, M.V., Ayers, D., Heideman, R.L. Pharmacogenetics (1991)
- Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate. Horsmans, Y., Lannes, D., Pessayre, D., Larrey, D. J. Hepatol. (1994)
- Mephenytoin: a reappraisal. Troupin, A.S., Ojemann, L.M., Dodrill, C.B. Epilepsia (1976)
- Effects of mephenytoin and methsuximide on the reaction time of pigeons. Blakely, E., Starin, S., Poling, A. Pharmacol. Biochem. Behav. (1988)
- Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Meehan, R.R., Gosden, J.R., Rout, D., Hastie, N.D., Friedberg, T., Adesnik, M., Buckland, R., van Heyningen, V., Fletcher, J., Spurr, N.K. Am. J. Hum. Genet. (1988)
- Family studies of mephenytoin hydroxylation deficiency. Inaba, T., Jurima, M., Kalow, W. Am. J. Hum. Genet. (1986)
- Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Kaisary, A., Smith, P., Jaczq, E., McAllister, C.B., Wilkinson, G.R., Ray, W.A., Branch, R.A. Cancer Res. (1987)
- Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Dalén, P., Alvan, G., Wakelkamp, M., Olsen, H. Pharmacogenetics (1996)
- Cytochrome P-450-dependent hydroxylation in migraine. Dahlöf, C., Alm, C., Bertling, I., Barret, L. Cephalalgia : an international journal of headache. (1992)
- Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol. Wells, P.G., Küpfer, A., Lawson, J.A., Harbison, R.D. J. Pharmacol. Exp. Ther. (1982)
- Cytochrome P-450 activity is differentially altered in severely injured patients. Harbrecht, B.G., Frye, R.F., Zenati, M.S., Branch, R.A., Peitzman, A.B. Crit. Care Med. (2005)
- Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients. Bourgeois, B.F., Küpfer, A., Wad, N., Egli, M. Epilepsia (1986)
- S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin. Sanz, E.J., Villén, T., Alm, C., Bertilsson, L. Clin. Pharmacol. Ther. (1989)
- Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. de Morais, S.M., Goldstein, J.A., Xie, H.G., Huang, S.L., Lu, Y.Q., Xia, H., Xiao, Z.S., Ile, N., Zhou, H.H. Clin. Pharmacol. Ther. (1995)
- Mephenytoin hydroxylation deficiency: kinetics after repeated doses. Küpfer, A., Desmond, P., Patwardhan, R., Schenker, S., Branch, R.A. Clin. Pharmacol. Ther. (1984)
- Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. Shimada, T., Misono, K.S., Guengerich, F.P. J. Biol. Chem. (1986)
- Participation of a rat liver cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin. Shimada, T., Guengerich, F.P. Mol. Pharmacol. (1985)
- Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis. Arns, P.A., Adedoyin, A., DiBisceglie, A.M., Waggoner, J.G., Hoofnagle, J.H., Wilkinson, G.R., Branch, R.A. Clin. Pharmacol. Ther. (1997)
- Diphenylhydantoin effects on salivary secretion and microsomal calcium accumulation and release. Watson, E.L., Siegel, I.A. Eur. J. Pharmacol. (1976)
- Molecular and fluorescent sterol approaches to probing lysosomal membrane lipid dynamics. Gallegos, A.M., Atshaves, B.P., Storey, S., Schoer, J., Kier, A.B., Schroeder, F. Chem. Phys. Lipids (2002)
- Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis. Parman, T., Chen, G., Wells, P.G. J. Biol. Chem. (1998)
- Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans. Partovian, C., Jacqz-Aigrain, E., Keundjian, A., Jaillon, P., Funck-Brentano, C. Clin. Pharmacol. Ther. (1995)
- Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland. Clasen, K., Madsen, L., Brøsen, K., Albøge, K., Misfeldt, S., Gram, L.F. Clin. Pharmacol. Ther. (1991)
- The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Balian, J.D., Sukhova, N., Harris, J.W., Hewett, J., Pickle, L., Goldstein, J.A., Woosley, R.L., Flockhart, D.A. Clin. Pharmacol. Ther. (1995)
- Bioequivalence revisited: influence of age and sex on CYP enzymes. Bebia, Z., Buch, S.C., Wilson, J.W., Frye, R.F., Romkes, M., Cecchetti, A., Chaves-Gnecco, D., Branch, R.A. Clin. Pharmacol. Ther. (2004)
- Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Jürgens, G., Lange, K.H., Reuther, L.Ø., Rasmussen, B.B., Brøsen, K., Christensen, H.R. Clin. Pharmacol. Ther. (2002)
- Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Simonsson, U.S., Jansson, B., Hai, T.N., Huong, D.X., Tybring, G., Ashton, M. Clin. Pharmacol. Ther. (2003)
- Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Bondolfi, G., Chautems, C., Rochat, B., Bertschy, G., Baumann, P. Psychopharmacology (Berl.) (1996)
- Developmental expression of human hepatic CYP2C9 and CYP2C19. Koukouritaki, S.B., Manro, J.R., Marsh, S.A., Stevens, J.C., Rettie, A.E., McCarver, D.G., Hines, R.N. J. Pharmacol. Exp. Ther. (2004)
- Cytochromes P450 mediating the N-demethylation of amitriptyline. Ghahramani, P., Ellis, S.W., Lennard, M.S., Ramsay, L.E., Tucker, G.T. British journal of clinical pharmacology. (1997)
- Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population. Sviri, S., Shpizen, S., Leitersdorf, E., Levy, M., Caraco, Y. Clin. Pharmacol. Ther. (1999)
- Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation. Küpfer, A., Branch, R.A. Clin. Pharmacol. Ther. (1985)
- Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man. Desiderio, C., Fanali, S., Küpfer, A., Thormann, W. Electrophoresis (1994)
- Capillary electrophoresis to assess drug metabolism induced in vitro using single CYP450 enzymes (Supersomes): application to the chiral metabolism of mephenytoin and methadone. Prost, F., Thormann, W. Electrophoresis (2003)
- Simultaneous liquid-chromatographic determination of some bronchodilators, anticonvulsants, chloramphenicol, and hypnotic agents, with Chromosorb P columns used for sample preparation. Svinarov, D.A., Dotchev, D.C. Clin. Chem. (1989)